Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage

被引:0
作者
Broderick, Lynne [1 ]
Chen, Wen-Hung [2 ]
Levy, Roger A. [3 ]
Foster, April Mitchell [1 ]
Figueroa, Cindy Umanzor [1 ]
Gairy, Kerry [4 ]
Chauhan, Deven [4 ]
机构
[1] QualityMetr, Johnston, RI USA
[2] GSK, Value Evidence & Outcomes, Collegeville, PA 19426 USA
[3] GSK, Global Med Affairs, Collegeville, PA USA
[4] GSK, Value Evidence & Outcomes, Brentford, Middlesex, England
来源
JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH | 2023年 / 10卷 / 02期
关键词
concept elicitation; systemic lupus erythematosus; qualitative research; organ damage; conceptual model; burden of disease; QUALITY-OF-LIFE; MEDICAL COSTS; PREDICTORS;
D O I
10.36469/jheor.2023.82228
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can lead to irreversible organ damage (OD). Data describing the patient burden of OD, as compared with SLE without OD, are limited. Objective: To develop a comprehensive conceptual model describing the burden experienced by patients living with SLE-associated OD. Methods: There were three phases to this qualitative study. First, a targeted literature review was conducted to inform a draft conceptual model. Second, key opinion leaders (KOLs) were interviewed to assess the draft conceptual model and help shape patient interview materials. Third, patients of different demographic backgrounds from across the United States were interviewed individually to gather their perspectives on living with SLE-associated OD. Data from concept elicitation interviews with KOLs and patients were coded and analyzed using NVivo software to identify the key concepts of the overall patient burden of SLE-associated OD. Findings from the KOL and patient interviews were used to finalize the conceptual model. Results: KOLs highlighted that SLE-associated OD carried a higher rate of mortality than SLE alone. Participants with SLE-associated OD (n = 40) experienced detrimental impacts across 4 areas of their lives: physical, cognitive, psychosocial functioning, and economic and work-related well-being. Physical impacts were described by all participants, often affecting their ability to perform everyday tasks. Many also described deterioration of cognitive functioning. Almost all participants experienced emotional impacts and challenges to their relationships and social lives resulting from living with SLE-associated OD. Additionally, SLE-associated OD imposed an economic burden including increased healthcare costs. SLE-associated OD had a more severe and debilitating impact on all aspects of the patient's quality of life than SLE prior to OD development, including further limitations in activities of daily living after the development of OD. Discussion: Study findings guided the development of a comprehensive conceptual model that fully represents the patient experience of living with SLE-associated OD, highlighting the additional burden of OD when compared with SLE alone. Conclusions: The conceptual model will inform improvements in disease management, which may result in better patient outcomes and aid development of clinical outcome assessments of disease burden.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 31 条
  • [1] Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach
    Barber, Megan R. W.
    Hanly, John G.
    Su, Li
    Urowitz, Murray B.
    St. Pierre, Yvan
    Romero-Diaz, Juanita
    Gordon, Caroline
    Bae, Sang-Cheol
    Bernatsky, Sasha
    Wallace, Daniel J.
    Merrill, Joan T.
    Isenberg, David A.
    Rahman, Anisur
    Ginzler, Ellen M.
    Petri, Michelle
    Bruce, Ian N.
    Dooley, Mary A.
    Fortin, Paul R.
    Gladman, Dafna D.
    Sanchez-Guerrero, Jorge
    Steinsson, Kristjan
    Ramsey-Goldman, Rosalind
    Khamashta, Munther A.
    Aranow, Cynthia
    Mackay, Meggan
    Alarcon, Graciela S.
    Manzi, Susan
    Nived, Ola
    Jonsen, Andreas
    Zoma, Asad A.
    van Vollenhoven, Ronald F.
    Ramos-Casals, Manuel
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Kalunian, Kenneth C.
    Inanc, Murat
    Kamen, Diane L.
    Peschken, Christine A.
    Jacobsen, Soren
    Askanase, Anca
    Farewell, Vernon
    Stoll, Thomas
    Buyon, Jill
    Clarke, Ann E.
    [J]. ARTHRITIS CARE & RESEARCH, 2020, 72 (12) : 1800 - 1808
  • [2] Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus
    Bjork, Mathilda
    Dahlstrom, Orjan
    Wettero, Jonas
    Sjowall, Christopher
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [3] Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
    Bruce, Ian N.
    O'Keeffe, Aidan G.
    Farewell, Vern
    Hanly, John G.
    Manzi, Susan
    Su, Li
    Gladman, Dafna D.
    Bae, Sang-Cheol
    Sanchez-Guerrero, Jorge
    Romero-Diaz, Juanita
    Gordon, Caroline
    Wallace, Daniel J.
    Clarke, Ann E.
    Bernatsky, Sasha
    Ginzler, Ellen M.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Alarcon, Graciela S.
    Fessler, Barri J.
    Fortin, Paul R.
    Petri, Michelle
    Steinsson, Kristjan
    Dooley, Mary Anne
    Khamashta, Munther A.
    Ramsey-Goldman, Rosalind
    Zoma, Asad A.
    Sturfelt, Gunnar K.
    Nived, Ola
    Aranow, Cynthia
    Mackay, Meggan
    Ramos-Casals, Manuel
    van Vollenhoven, Ronald F.
    Kalunian, Kenneth C.
    Ruiz-Irastorza, Guillermo
    Lim, Sam
    Kamen, Diane L.
    Peschken, Christine A.
    Inanc, Murat
    Urowitz, Murray B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (09) : 1706 - 1713
  • [4] Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
    Chambers, Sharon A.
    Allen, Elizabeth
    Rahman, Anisur
    Isenberg, David
    [J]. RHEUMATOLOGY, 2009, 48 (06) : 673 - 675
  • [5] Charmaz K., 2014, CONSTRUCTING GROUNDE
  • [6] Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study
    Chiu, Y. M.
    Chuang, M. T.
    Lang, H. C.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2016, 36 (11) : 1507 - 1514
  • [7] Di Battista M, 2018, CLIN EXP RHEUMATOL, V36, P763
  • [8] 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Alunno, Alessia
    Aringer, Martin
    Bajema, Ingeborg
    Boletis, John N.
    Cervera, Ricard
    Doria, Andrea
    Gordon, Caroline
    Govoni, Marcello
    Houssiau, Frederic
    Jayne, David
    Kouloumas, Marios
    Kuhn, Annegret
    Larsen, Janni L.
    Lerstrom, Kirsten
    Moroni, Gabriella
    Mosca, Marta
    Schneider, Matthias
    Smolen, Josef S.
    Svenungsson, Elisabet
    Tesar, Vladimir
    Tincani, Angela
    Troldborg, Anne
    van Vollenhoven, Ronald
    Wenzel, Joerg
    Bertsias, George
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) : 736 - 745
  • [9] Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective
    Gallop, K.
    Nixon, A.
    Swinburn, P.
    Sterling, K. L.
    Naegeli, A. N.
    Silk, M. E. T.
    [J]. LUPUS, 2012, 21 (09) : 934 - 943
  • [10] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369